TG Therapeutics Inc
NASDAQ:TGTX

Watchlist Manager
TG Therapeutics Inc Logo
TG Therapeutics Inc
NASDAQ:TGTX
Watchlist
Price: 39.3 USD 6.12% Market Closed
Market Cap: 6.2B USD

Intrinsic Value

The intrinsic value of one TGTX stock under the Base Case scenario is 34.92 USD. Compared to the current market price of 39.3 USD, TG Therapeutics Inc is Overvalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TGTX Intrinsic Value
34.92 USD
Overvaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
TG Therapeutics Inc

Valuation History Unavailable

Historical valuation for TGTX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TGTX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about TG Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
TG Therapeutics Inc

Current Assets 566.4m
Cash & Short-Term Investments 311m
Receivables 129.2m
Other Current Assets 126.2m
Non-Current Assets 11.3m
Long-Term Investments 808k
PP&E 7.2m
Other Non-Current Assets 3.4m
Efficiency

Free Cash Flow Analysis
TG Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
TG Therapeutics Inc

Revenue
386.4m USD
Cost of Revenue
-48.6m USD
Gross Profit
337.8m USD
Operating Expenses
-278m USD
Operating Income
59.8m USD
Other Expenses
-20.7m USD
Net Income
39.2m USD
Fundamental Scores

TGTX Profitability Score
Profitability Due Diligence

TG Therapeutics Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional ROIC
46/100
Profitability
Score

TG Therapeutics Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

TGTX Solvency Score
Solvency Due Diligence

TG Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
60/100
Solvency
Score

TG Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TGTX Price Targets Summary
TG Therapeutics Inc

Wall Street analysts forecast TGTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TGTX is 43.35 USD with a low forecast of 11.11 USD and a high forecast of 57.75 USD.

Lowest
Price Target
11.11 USD
72% Downside
Average
Price Target
43.35 USD
10% Upside
Highest
Price Target
57.75 USD
47% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

TG Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TGTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TGTX Insider Trading
Buy and sell transactions by insiders

TGTX News

Other Videos
What is the Intrinsic Value of one TGTX stock?

The intrinsic value of one TGTX stock under the Base Case scenario is 34.92 USD.

Is TGTX stock undervalued or overvalued?

Compared to the current market price of 39.3 USD, TG Therapeutics Inc is Overvalued by 11%.

Back to Top